Bagge K, Sivapalan P, Eklof J, Hertz FB, Andersen CO, Hansen EF, et al. Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid-data from 43,636 outpatients. Respir Res 2021;22(1):11. https://www.ncbi.nlm.nih.gov/pubmed/33413341
Biancardi E, Fennell M, Rawlinson W, Thomas PS. Viruses are frequently present as the infecting agent in acute exacerbations of chronic obstructive pulmonary disease in patients presenting to hospital. Intern Med J 2016;46(10):1160-5. https://www.ncbi.nlm.nih.gov/pubmed/27515577
Butler CC, Gillespie D, White P, Bates J, Lowe R, Thomas-Jones E, et al. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. N Engl J Med 2019;381(2):111-20. https://www.ncbi.nlm.nih.gov/pubmed/31291514
Chen K, Pleasants KA, Pleasants RA, Beiko T, Washburn RG, Yu Z, et al. A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations. COPD 2020;17(3):311-7. https://www.ncbi.nlm.nih.gov/pubmed/32456479
Dabscheck E, George J, Hermann K, McDonald CF, McDonald VM, McNamara R, et al. COPD-X Australian guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2022 update. Med J Aust 2022;217(8):415-23. https://www.ncbi.nlm.nih.gov/pubmed/36116098
Fanning M, McKean M, Seymour K, Pillans P, Scott I. Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital. Intern Med J 2014;44(9):903-10. https://www.ncbi.nlm.nih.gov/pubmed/24963727
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2025. version 2025. Accessed 22 January 2025. https://goldcopd.org/2025-gold-report/
Herath SC, Normansell R, Maisey S, Poole P. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2018;10(10):CD009764. https://www.ncbi.nlm.nih.gov/pubmed/30376188
Janjua S, Mathioudakis AG, Fortescue R, Walker RA, Sharif S, Threapleton CJ, et al. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Cochrane Database Syst Rev 2021;1(1):CD013198. https://www.ncbi.nlm.nih.gov/pubmed/33448349
Llor C, Moragas A, Miravitlles M, Mesquita P, Cordoba G. Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis. Pulm Pharmacol Ther 2022;72:102111. https://www.ncbi.nlm.nih.gov/pubmed/35032637
Messous S, Trabelsi I, Bel Haj Ali K, Abdelghani A, Ben Daya Y, Razgallah R, et al. Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial. Ther Adv Respir Dis 2022;16:17534666221099729. https://www.ncbi.nlm.nih.gov/pubmed/35657073
Miravitlles M, Kruesmann F, Haverstock D, Perroncel R, Choudhri SH, Arvis P. Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis. Eur Respir J 2012;39(6):1354-60. https://www.ncbi.nlm.nih.gov/pubmed/22034649
Ni W, Shao X, Cai X, Wei C, Cui J, Wang R, et al. Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis. PLoS One 2015;10(3):e0121257. https://www.ncbi.nlm.nih.gov/pubmed/25812085
Stockley R. Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest 2000;117(6):1638-45. https://pubmed.ncbi.nlm.nih.gov/10858396/
van Velzen P, Ter Riet G, Bresser P, Baars JJ, van den Berg BTJ, van den Berg JWK, et al. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial. Lancet Respir Med 2017;5(6):492-99. https://pubmed.ncbi.nlm.nih.gov/28483402/
Vollenweider DJ, Frei A, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2018;10:CD010257. https://www.ncbi.nlm.nih.gov/pubmed/30371937
Wedzicha JA, Calverley PMA, Albert RK, Anzueto A, Criner GJ, Hurst JR, et al. Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J 2017;50(3). https://www.ncbi.nlm.nih.gov/pubmed/28889106
Wedzicha JAEC-C, Miravitlles M, Hurst JR, Calverley PM, Albert RK, Anzueto A, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J 2017;49(3). https://www.ncbi.nlm.nih.gov/pubmed/28298398
